Most Popular

Check out the most popular stories and multimedia features across the site right now

New Opioid Approved - Dsuvia

The Pharmalot View

The military pushed it for the battlefield. The FDA went along. Is the newest opioid any better?

By Ed Silverman

Memorial Sloan Kettering

Hospitals

Top cancer center’s business deals created a web of conflicts, say ethics experts

By Casey Ross and Ike Swetlitz

advertisement

Cambridgeport

Exclusive

New documents shed light on secretive ElevateBio, next step for former Alexion execs

By Kate Sheridan

advertisement

Watchdogs illustration

The Watchdogs

Amid ethics outcry, should journals publish the ‘CRISPR babies’ paper?

Superbug Q And A

First Opinion

What’s holding pharma back from the next antibiotic breakthrough?

By Peter Bak

Gottlieb Generic Drugs

Politics

Gottlieb blasts high insulin prices, touts far-off new rules he says will spur competition in that market

By Nicholas Florko

German pharmacy

Pharmalot

Dozens of groups attack Trump plan to peg drug prices to what other countries pay

By Ed Silverman

advertisement

PhRMA & congress

Politics

The drug industry is headed back to Congress to make its case. Will Democrats keep the door open?

By Nicholas Florko

advertisement

Francis Collins

Politics

NIH to spend up to $20 million on search for alternatives to fetal tissue for research

By Ike Swetlitz

Prescription pill bottles

First Opinion

I’ve been forced to go through ‘step therapy.’ Don’t make Medicare Part B participants do that

By Elizabeth Krempley

Politics

HIV research halted after NIH freezes acquisition of fetal tissue

By Kate Sheridan

He Jiankui

Exclusive

Ethical issues plagued newly surfaced paper by ‘CRISPR babies’ scientist

By Sharon Begley

In the Lab

A shot-in-the-dark email leads to a century-old family treasure — and hope of cracking a deadly flu’s secret

By Helen Branswell

Hoarding Opioids

First Opinion

Overzealous use of the CDC’s opioid prescribing guideline is harming pain patients

By Kate M. Nicholson, Diane E. Hoffman, and Chad D. Kollas

First Opinion

A makeover for oral PrEP: designing real-world HIV prevention for women

By Ann S. Kim

"beyond the diagnosis" 2016

Politics

After outcry, NIH apologizes for turning away portrait of person with rare disease

By Kate Sheridan

FDA-Blood Sugar Monitor

Health

FDA approves first blood sugar monitor without finger pricks

By Associated Press

Moral Injury

First Opinion

Physicians aren’t ‘burning out.’ They’re suffering from moral injury

By Simon G. Talbot and Wendy Dean

Peter Lurie

In the Lab

Lawsuit alleges NIH, FDA let clinical trial sponsors off the hook